Table 2.
Patient | Disease | Day 13* ALC (×103/μL) | 13* PB k | 13* LN k | 13* BM k | 28* PB k | 35* PB k |
---|---|---|---|---|---|---|---|
HW01 | CLL | 243 | 0.42 | 1.65 | 0.42 | 0.42 | 0.38 |
HW02 | SLL | 3 | - | 1.27 | - | - | - |
HW03 | CLL | 37 | 0.62 | - | 0.23 | 0.79 | 0.79 |
HW04 | CLL | 163 | 1.66 | 2.92 | 0.96 | 1.69 | - |
HW05 | CLL | 20 | 0.08 | - | 0.18 | 0.11 | 0.11 |
HW06 | CLL | 142 | 0.48 | 1.24 | - | 0.53 | - |
HW07 | SLL | 2 | 2.11 | 0.91 | 0.50 | 2.04 | - |
HW08 | CLL | 116 | 1.12 | 1.37 | 0.76 | 0.97 | - |
HW09 | CLL | 75 | 0.34 | 0.82 | - | 0.49 | 0.47 |
HW11 | CLL | 30 | 0.12 | 0.42 | 0.51 | 0.14 | 0.14 |
HW12 | SLL | 4 | 0.49 | 0.88 | 0.74 | 0.36 | 0.31 |
HW13 | CLL | 13 | 0.68 | 1.00 | - | 0.64 | 0.52 |
HW15 | CLL | 23 | 1.42 | 1.56 | - | 0.92 | 1.36 |
HW18 | CLL | 33 | 0.5 | 1.44 | - | - | - |
HW20 | CLL | 101 | 1.74 | 3.32 | - | - | - |
±2 days; ALC, Absolute lymphocyte count;
PB, Peripheral blood; BM, Bone marrow; LN, Lymph node
6 patients provided PB, LN, and BM; 6 patients provided PB and LN; 2 patients provided PB and BM and in one patient only the LN sample could be analyzed.